Syngene International Limited is an India-based integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health ...

Syngene International, operating in the Medical Research Services sector and classified as a Midcap on the BSE, currently has its share price at ₹701.3. The stock has experienced fluctuations ...

Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

On Tuesday, Kotak analysts began coverage of Syngene International Ltd (NSE:SYNN) (SYNG:IN), rating the stock as a Buy with a price target of INR875.00. The firm highlighted Syngene’s position ...

All relevant comments and Syngene International Ltd share chat regarding the SYNN NSE share news are listed here in the SYNN forum. View and contribute to the SYNN share chat. Discuss Syngene ...

Top Picks: Kotak Institutional Equities bets on Piramal Pharma, Syngene International, and Indegene; Here's everything you need to know (image Source: Freepik) The brokerage firm Kotak ...

KUALA LUMPUR, Malaysia, April 08, 2025 (GLOBE NEWSWIRE) -- CBL International Limited (NASDAQ: BANL), the Nasdaq-listed entity of Banle Group, today announced it will file its Annual Report on Form ...

Good morning, everyone, and welcome to CBL International Limited's Annual Results Presentation for the year ended December 31st, 2024. Today's meeting will be conducted in English with ...

ETT Limited is not a new name — the company has previously executed high-end digital campaigns and marketing projects for both national and international clients. However, this newly secured ...